STOCK TITAN

MCK Form 4: SVP Rutledge Napoleon B. Jr. Sells 329 Shares via 10b5-1 Plan

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Rutledge Napoleon B. Jr., SVP, Controller & CAO of McKesson Corporation (MCK), reported a sale of common stock under a pre-existing Rule 10b5-1 trading plan. The filing shows a transaction on 08/08/2025 in which 329 shares were sold at $663.67 per share, leaving the reporting person with 657 shares held directly. The form indicates the sale was executed pursuant to a plan adopted February 7, 2025, and the form was signed by an attorney-in-fact on 08/11/2025. The filing contains only this single non-derivative sale disclosure and does not provide additional company financial information.

Positive

  • Sale executed under a documented Rule 10b5-1 plan, which supports non-discretionary trading intent
  • Full Form 4 disclosure includes transaction details: date, price ($663.67), quantity (329 shares), and post-transaction holdings (657 shares)

Negative

  • Insider reduced direct holdings by 329 shares, leaving 657 shares owned directly
  • Filing contains no additional context about other holdings, other transactions, or company financials

Insights

TL;DR: A routine insider sale of 329 shares under a 10b5-1 plan; impact on capitalization is immaterial.

The disclosed sale of 329 shares at $663.67 reduces the reporting person’s direct holdings to 657 shares. Executions under Rule 10b5-1 plans are pre-arranged and generally indicate a non-discretionary sale rather than ad hoc trading. Given the small absolute share count relative to McKesson’s market capitalization, the transaction is unlikely to be material to investors or to affect the company’s capital structure.

TL;DR: Properly disclosed as a Rule 10b5-1 sale and executed via attorney-in-fact signature; disclosure meets basic Form 4 requirements.

The form identifies the reporter, relationship to the issuer, transaction date, transaction code (S for sale), number of shares sold, sale price, and post-transaction holdings, and includes an explanatory note that the sale was pursuant to a February 7, 2025 plan. The signature by an attorney-in-fact is present with a date. The filing therefore contains the core elements required for Section 16 reporting for a single non-derivative sale.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rutledge Napoleon B JR

(Last) (First) (Middle)
6555 NORTH STATE HWY 161

(Street)
IRVING TX 75039

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MCKESSON CORP [ MCK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Controller & CAO
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 S 329(1) D $663.67 657 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Sale pursuant to a previously adopted plan dated February 7, 2025, in compliance with Rule 10b5-1(c).
/s/ Sarah Ahmad Ali, Attorney-in-fact 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did McKesson insider Rutledge Napoleon B. Jr. report on Form 4?

The filing reports a sale of 329 shares of McKesson common stock executed on 08/08/2025 at a price of $663.67 per share, leaving 657 shares held directly.

Was the sale executed under a 10b5-1 plan for MCK insider transactions?

Yes. The Form 4 indicates the sale was made pursuant to a plan adopted on February 7, 2025 to satisfy Rule 10b5-1(c) affirmative defense conditions.

Who signed the Form 4 for the McKesson insider filing?

The Form 4 is signed by Sarah Ahmad Ali, Attorney-in-fact with a signature date of 08/11/2025.

How many shares does the reporting person own after the reported transaction?

After the reported sale, the reporting person beneficially owns 657 shares directly.
McKesson

NYSE:MCK

MCK Rankings

MCK Latest News

MCK Latest SEC Filings

MCK Stock Data

117.98B
122.44M
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
IRVING